# Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure

> **NCT05885607** · — · ENROLLING_BY_INVITATION · sponsor: **University of Pennsylvania** · enrollment: 40 (estimated)

## Conditions studied

- Heart Failure NYHA Class II
- Heart Failure NYHA Class III
- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05885607
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-06-27
- **Primary completion:** 2026-02-09
- **Final completion:** 2026-03-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05885607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05885607, "Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05885607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*